Background: The goal of this systematic review and meta-analysis is to determine the effect of diet on telomere length. Methods: We searched the following databases: MEDLINE, Embase, LILACS, CINAHL, ISI Web of Science, and Scopus, as well as the Cochrane Central Register of Controlled Trials and the National Institutes of Health, from inception to December 2016. Articles that assessed effects of diet on telomere length were included. Results: A total of 2,128 studies were identified, 30 were read in full, and 7 were systematically reviewed. Five RCTs were included in the meta-analysis, covering 9 diets; a total of 533 participants were included. Study heterogeneity (I2) was 89%, and differences were not identified regarding average telomere lengths (mean difference 1.06; 95% CI –1.53 to 3.65). Conclusion: The available evidence suggests that there is no effect of diet on telomere length, but the strong heterogeneity in the type and duration of dietary interventions does not allow any final statement on the absence of an effect of diet on telomere length.

Keywords:
Age, Diet, Telomere
1.
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G: The hallmarks of aging. Cell 2013; 153: 1194–1217.
2.
Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585–621.
3.
Sitte N, Merker K, Von Zglinicki T, Grune T, Davies K: Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I – effects of proliferative senescence. FASEB J 2000; 14: 2495–2502.
4.
Gems D, Partridge L: Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol 2013; 75: 621–644.
5.
Blackburn E: Telomere states and cell fates. Nature 2000; 408: 53–56.
6.
Kong CM, Lee XW, Wang X: Telomere shortening in human diseases. FEBS J 2013; 280: 3180–3193.
7.
Mundstock E, Sarria EE, Zatti H, Mattos Louzada F, Kich Grun L, Herbert Jones M, et al: Effect of obesity on telomere length: systematic review and meta-analysis. Obesity (Silver Spring) 2015; 23: 2165–2174.
8.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West D, Ho PL, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015.
9.
Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al: Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662–664.
10.
Kananen L, Surakka I, Pirkola S, Suvisaari J, Lönnqvist J, Peltonen L, et al: Childhood adversities are associated with shorter telomere length at adult age both in individuals with an anxiety disorder and controls. PLoS One 2010; 5:e10826.
11.
D’Mello MJJ, Ross SA, Anand SS, Gerstein H, McQueen M, Yusuf S, et al: Telomere length and risk of myocardial infarction in a multiethnic population: the INTERHEART study. J Am Coll Cardiol 2016; 67: 1863–1865.
12.
Fretts AM, Howard BV, Siscovick DS, Best LG, Beresford SA, Mete M, et al: Processed meat, but not unprocessed red meat, is inversely associated with leukocyte telomere length in the Strong Heart Family Study. J Nutr 2016; 146: 2013–2018.
13.
Kasielski M, Eusebio MO, Pietruczuk M, Nowak D: The relationship between peripheral blood mononuclear cells telomere length and diet – unexpected effect of red meat. Nutr J 2016; 15: 68.
14.
Previdelli ÁN, Andrade SC, Pires MM, Ferreira SR, Fisberg RM, Marchioni DM: Índice de Qualidade da Dieta Revisado para população brasileira. Rev Saude Publica 2011; 45: 794–798.
15.
Shivappa N, Wirth MD, Hurley TG, Hébert JR: Association between the dietary inflammatory index (DII) and telomere length and C-reactive protein from the National Health and Nutrition Examination Survey-1999– 2002. Mol Nutr Food Res 2017; 61: 1600630.
16.
García-Calzón S, Gea A, Razquin C, Corella D, Lamuela-Raventós RM, Martínez JA, et al: Longitudinal association of telomere length and obesity indices in an intervention study with a Mediterranean diet: the PREDIMED-NAVARRA trial. Int J Obes (Lond) 2014; 38: 177–182.
17.
Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, et al: Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial. Brain Behav Immun 2013; 28: 16–24.
18.
Aunan JR, Watson MM, Hagland HR, Søreide K: Molecular and biological hallmarks of ageing. Br J Surg 2016; 103:e29–e46.
19.
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264–269, W64.
20.
Higgins JP, Green S: Cochrane Handbook for Systematic Reviews of Interventions: Coch­rane Book Series. Version 5.1.0. Chichester, John Wiley & Sons, 2008.
https://doi.org/10.1002/9780470712184
.
21.
O’Callaghan N, Parletta N, Milte CM, Benassi-Evans B, Fenech M, Howe PR: Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled pilot study. Nutrition 2014; 30: 489–491.
22.
Marin C, Delgado-Lista J, Ramirez R, Carracedo J, Caballero J, Perez-Martinez P, et al: Mediterranean diet reduces senescence-associated stress in endothelial cells. Age (Dordr) 2012; 34: 1309–1316.
23.
Mason C, Risques RA, Xiao L, Duggan CR, Imayama I, Campbell KL, et al: Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women. Obesity (Silver Spring) 2013; 21:E549–E554.
24.
Tosevska A, Franzke B, Hofmann M, Vier­heilig I, Schober-Halper B, Oesen S, et al: Circulating cell-free DNA, telomere length and bilirubin in the Vienna Active Ageing Study: exploratory analysis of a randomized, controlled trial. Sci Rep 2016; 6: 38084.
25.
Borresen EC, Brown DG, Harbison G, Taylor L, Fairbanks A, O’Malia J, et al: A randomized controlled trial to increase navy bean or rice bran consumption in colorectal cancer survivors. Nutr Cancer 2016; 68: 1269–1280.
26.
Thomson CA, Crane TE, Miller A, Garcia DO, Basen-Engquist K, Alberts DS: A randomized trial of diet and physical activity in women treated for stage II–IV ovarian cancer: rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): an NRG Oncology/Gynecologic Oncology Group (GOG-225) study. Contemp Clin Trials 2016; 49: 181–189.
27.
Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al: GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013; 66: 719–725.
28.
Freitas-Simoes TM, Ros E, Sala-Vila A: Nutrients, foods, dietary patterns and telomere length: update of epidemiological studies and randomized trials. Metabolism 2016; 65: 406–415.
29.
Deng W, Cheung ST, Tsao SW, Wang XM, Tiwari AF: Telomerase activity and its association with psychological stress, mental disorders, lifestyle factors and interventions: a systematic review. Psychoneuroendocrinol­ogy 2015; 64: 150–163.
30.
Vidaček NŠ, Nanić L, Ravlić S, Sopta M, Gerić M, Gajski G, et al: Telomeres, nutrition, and longevity: can we really navigate our aging? J Gerontol A Biol Sci Med Sci 2017; 73: 39–47.
31.
Malavolta M, Mocchegiani E (eds): Molecular Basis of Nutrition and Aging, ed 1. Amsterdam, Academic Press, 2016.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.